m+Medelevator.RU
← Поиск публикаций
Infectious diseases now · 2025

Management of catheter-related septic thrombosis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Hémar Victor, Chaussade Hélène, Rivoisy Claire, Contis Anne, Vandenhende Marie-Anne, Bronnimann Didier, Prola Juliette, Delassasseigne Céline, Galli Gaël, Constans Joël, Bonnet Fabrice

Аннотация

INTRODUCTION: The use of intravascular catheters is associated with a risk of catheter-related septic thrombosis (CRST), which management remains highly variable due to a lack of robust scientific evidence. This study aimed to describe current practices in France through a systematic survey.

METHODS: A web-based survey was disseminated via 10 French medical societies between June and October 2024.

RESULTS: Among 156 respondents, 69 were infectious disease specialists. For catheter-related bloodstream infections, ultrasound imaging is not routinely performed by 60 % of respondents but is typically performed in the presence of local inflammatory signs or antimicrobial therapy (AMT) failure. Over 60 % of respondents reported prescribing AMT for ≤ 21 days. In cases of CRST involving a deep vein (DV), more than 80 % of respondents considered the use of curative anticoagulation. For proximal DV CRST, 126 of 156 (81 %) respondents performed follow-up ultrasound imaging to assess venous repermeabilization. The most frequently cited research priorities included the need for and appropriate use of anticoagulation (n = 71/156; 46 %), as well as AMT optimal duration (n = 47/156; 30 %).

CONCLUSION: Despite the heterogeneity in clinical practice, our findings highlight a prevailing trend toward prescribing AMT for ≤ 21 days and the use of curative anticoagulation in cases of DV thrombosis. However, these approaches require further investigation through well-designed studies to establish their benefit.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты